← Back to Search

Remote Therapeutic Monitoring for Parkinson's Disease

N/A
Recruiting
Led By Miriam Rafferty, PT, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily, through study completion, average 1 year
Awards & highlights

Study Summary

"This trial aims to study how physical activity and exercise habits change in individuals with Parkinson's Disease and Multiple Sclerosis over a 1-year period using an online monitoring platform."

Who is the study for?
This trial is for people who can walk on their own or with a cane, have Parkinson's Disease (mild to moderate stages), Parkinsonism, or Multiple Sclerosis. They should be willing to increase physical activity and must agree to the terms of using a remote monitoring app on their smartphone.Check my eligibility
What is being tested?
The study is testing how well a cloud-based remote monitoring platform tracks exercise and physical activity in individuals with Parkinson's Disease or Multiple Sclerosis over one year.See study design
What are the potential side effects?
Since this trial involves activity monitoring through an app, there are no direct medical side effects. However, participants may experience privacy concerns related to data sharing or stress from regular self-monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily, through study completion, average 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily, through study completion, average 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Activity Metric 1
Physical Activity Metric 2
Secondary outcome measures
Exercise Self Efficacy
Quality of Life from PROMIS 10-b
Quality of Life from PROMIS-29

Trial Design

1Treatment groups
Experimental Treatment
Group I: Remote Therapeutic MonitoringExperimental Treatment1 Intervention
Participants will receive 1 year of remote therapeutic monitoring via a connected health app and personal activity tracker to monitor their physical activity and exercise behaviors.

Find a Location

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
194 Previous Clinical Trials
16,712 Total Patients Enrolled
Miriam Rafferty, PT, PhDPrincipal InvestigatorShirley Ryan AbilityLab

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing efforts to enroll patients in this current medical study?

"According to the information available on clinicaltrials.gov, this research is currently in search of eligible participants. Initial publication of the trial occurred on April 1st, 2024, with the most recent revision documented on April 14th, 2024."

Answered by AI

What is the current number of individuals eligible for enrollment in this clinical research study?

"Indeed, information retrieved from clinicaltrials.gov highlights the ongoing recruitment of participants for this particular clinical trial. The trial was first listed on April 1st, 2024 and underwent its latest update on April 14th, 2024. This study aims to enroll a total of 200 subjects at one site."

Answered by AI

Is the trial open to participants who are younger than 65 years old?

"Individuals aged 18 to 89 years are eligible for inclusion in this clinical trial."

Answered by AI
~133 spots leftby Mar 2028